A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.
about
Amyotrophic lateral sclerosis and environmental factorsTrophic factors as modulators of motor neuron physiology and survival: implications for ALS therapyNeuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.The protective effect of growth hormone on Cu/Zn superoxide dismutase-mutant motor neuronsThe neuroprotective effects of human growth hormone as a potential treatment for amyotrophic lateral sclerosis.Intraspinal stem cell transplantation for amyotrophic lateral sclerosisExperimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs.The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans.Manganese and the Insulin-IGF Signaling Network in Huntington's Disease and Other Neurodegenerative Disorders.Neurotrophic and Neuroregenerative Effects of GH/IGF1.Specific Physical Exercise Improves Energetic Metabolism in the Skeletal Muscle of Amyotrophic-Lateral- Sclerosis Mice.Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment.Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis.Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
P2860
Q26749342-5A1E83D5-CD96-4F55-A661-AFFA18EFCB98Q26999881-FFBE4287-DE32-4915-B328-C51EAF215CBBQ34222849-1D2954E8-CAE2-45F2-9041-02E3E2EC508CQ34401653-3314A82A-5D3C-4753-928E-B6E677D9855FQ35078519-6191461E-9CCC-49A5-84A7-6F075D1179AAQ36110708-961FD167-04BF-4345-B484-448266541E15Q36679757-E4BC9F34-9204-4272-BE53-CB827D83F679Q38223292-C3A045CD-1C4D-423B-AE64-703B06338112Q41052218-7CA81928-5076-49C3-83F2-1C29BA4D293EQ46284159-56017E8F-A426-4C2F-92AA-5B41A4F67D18Q46309597-368095DF-9F53-432D-B98B-0E41729B298AQ47152037-F8F7ED17-DBA7-4BDA-9EE2-596018251A6DQ47155349-EBBA6C55-F277-43F5-9A8F-9E06DBF1D49EQ47815494-2E839DCF-1910-4D09-B9BF-F1A4A43AD9E6Q48116439-CFD3F2FC-07CE-4FF7-8E72-194065419C9CQ53076018-5F373180-70B7-4335-A493-B780E8D83F9E
P2860
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
A randomized controlled clinic ...... imaging, and hormonal results.
@en
A randomized controlled clinic ...... imaging, and hormonal results.
@nl
type
label
A randomized controlled clinic ...... imaging, and hormonal results.
@en
A randomized controlled clinic ...... imaging, and hormonal results.
@nl
prefLabel
A randomized controlled clinic ...... imaging, and hormonal results.
@en
A randomized controlled clinic ...... imaging, and hormonal results.
@nl
P2093
P2860
P50
P1433
P1476
A randomized controlled clinic ...... imaging, and hormonal results.
@en
P2093
Alessandro Filla
Angela Marsili
Barbara Carotenuto
Carlo Rinaldi
Gaetano Perrotta
Giuseppe De Michele
Raffaele Piro
Tecla Tucci
Vincenzo Palma
P2860
P2888
P304
P356
10.1007/S00415-011-6146-2
P577
2011-06-25T00:00:00Z
P6179
1009189398